chart, page-3

FiendishRedbeard...

The first massive rise day (1 Feb) was severely impacted by the typical pump-and-dump brigade doing the rounds of the micro-caps at that time...as a result, the stock rose significantly, on good volume commensurate with the re-rating announcement released, but then was savagely sold-down on the back of little more than trader induced panic.

By the end of the day...they all bought in...and all sold out...leaving the stock more or less back where it started. It looked like a pump-and-dump, and to some extent was impacted by pump-and-dump chasers...but in actual fact there was much more to it.

Most onlookers would have discounted the stock as being nothing more than just another Biotech special and would have otherwise let it die a slow death.

As I see it, a real re-rating scenario is unfolding here...flagged with the first big volume day (1 Feb) and confirmed on the following break-out day (10 Feb), which was actually driven by the pending Channel 7 story, which followed a few days later, clearly providing the catalyst needed to bring forward investor buying that might otherwise have waited.

There is a new emphasis here and thanks to the media coverage, competition for stock which may well prevent this thing simply falling back to sleep as some of the more conservative and gradual accumulators might have preferred.

So...whether this breaks 10c in the next few days (or today?)...or not...probably doesn't really matter for the longer term, which is clearly seeing a re-rating of a decent Aussie Biotech, with a real product, with genuine potential to make good money for shareholders as a world-first mover.

Exactly how this transforms to share price performance on a daily basis will be driven more by potential activity away from the screen, behind the scenes via corporate deals and/or peer assessment and potential value measure by those that know...in the whole, we will simply be bystanders to this process.

I think the value here is real, and at current prices, POH is not even close to her achievable market cap ranges.

Cheers!